NS-398 Induces Apoptosis in Human Esophageal Cancer Cells Through Inhibition of NF-kappaB Downstream Regulation of Cyclooxygenase-2

REFERENCES

• Parkin D. M., Pisani P., Ferlay J. Estimates of the worldwide incidence of 25 major cancers in 1990. Int J Cancer 1999; 80: 827–841
   PubMed Web of Science ®Google Scholar
• Li L. D., Lu F. Z., Zhang S. W., Mu R., Sun X. D., Huangpu X. M., Sun J., Zhou Y. S., Ouyang N. H., Rao K. Q., Chen Y. D., Sun A. M., Xue Z. F., Xia Y. Analysis of cancer mortality and distribution in China from year 1990 through 1992: An epidemiological study [in Chinese]. Chin J Oncol 1996; 18: 403–407
   Google Scholar
• Hou J., Lin P. S., Chen Z. F. A study survey of esophageal cancer in Cixian of Hebei. Chung Liu Fang Zhi Yan Jiu 1998; 25: 73–75
   Google Scholar
• Li H., Yao S. C. Surgical treatment for carcinoma of the esophagus in Chinese language publications. Br J Surg 1997; 84: 855–857
   PubMed Web of Science ®Google Scholar
• Elder D. J., Halton D. E., Crew T. E., Paraskeva C. Apoptosis induction and cyclooxygenase-2 regulation in human colorectal adenoma and carcinoma cell lines by the cyclooxygenase-2-selective non-steroidal anti-inflammatory drug NS-398. Int J Cancer 2000; 86: 553–560
   PubMed Web of Science ®Google Scholar
• Farrow D. C., Vaughan T. L., Hansten P. D., Stanford J. L., Risch H. A., Gammon M. D., et al. Use of aspirin and other nonsteroidal anti-inflammatory drugs and risk of esophageal and gastric cancer. Cancer Epidemiol Biomarkers Prev 1998; 7: 97–102
   PubMed Web of Science ®Google Scholar
• Funkhouser E. M., Sharp G. B. Aspirin and reduced risk of esophageal carcinoma. Cancer 1995; 76: 1116–1119
   PubMed Web of Science ®Google Scholar
• Jones D. A., Carlton D. P., McIntyre T. M., Zimmerman G. A., Prescott S. M. Molecular cloning of human prostaglandin endoperoxide synthase type II and demonstration of expression in response to cytokines. J Biol Chem 1993; 268: 9049–9054
   PubMed Web of Science ®Google Scholar
• Hamasaki Y., Kitzler J., Hardman R., Nettesheim P., Eling T. E. Phorbol ester and epidermal growth factor enhance the expression of two inducible prostaglandin H synthase genes in rat tracheal epithelial cells. Arch Biochem Biophys 1993; 304: 226–234
   PubMed Web of Science ®Google Scholar
• DuBois R. N., Awad J., Morrow J., Roberts L. J., 2nd, Bishop P. R. Regulation of eicosanoid production and mitogenesis in rat intestinal epithelial cells by transforming growth factor-alpha and phorbol ester. J Clin Invest 1994; 93: 493–498
   PubMed Web of Science ®Google Scholar
• Wilson K. T., Fu S., Ramanujam K. S., Meltzer S. J. Increased expression of inducible nitric oxide synthase and cyclooxygenase-2 in Barrett's esophagus and associated adenocarcinomas. Cancer Res 1998; 58: 2929–2934
   PubMed Web of Science ®Google Scholar
• Zimmermann K. C., Sarbia M., Weber A. A., Borchard F., Gabbert H. E., Schror K. Cyclooxygenase-2 expression in human esophageal carcinoma. Cancer Res 1999; 59: 198–204
   PubMed Web of Science ®Google Scholar
• Xu X. C. COX-2 inhibitors in cancer treatment and prevention, a recent development. Anticancer Drugs 2002; 13: 127–137
   PubMed Web of Science ®Google Scholar
• Zha S., Yegnasubramanian V., Nelson W. G., Isaacs W. B., De Marzo A. M. Cyclooxygenases in cancer: progress and perspective. Cancer Lett 2004; 215: 1–20
   PubMed Web of Science ®Google Scholar
• Xu X. M., Sansores-Garcia L., Chen X. M., Matijevic-Aleksic N., Du M., Wu K. K. Suppression of inducible cyclooxygenase 2 gene transcription by aspirin and sodium salicylate. Proc Natl Acad Sci USA 1999; 96: 5292–5297
   PubMed Web of Science ®Google Scholar
• Lim J. W., Kim H., Kim K. H. Nuclear factor-kappaB regulates cyclooxygenase-2 expression and cell proliferation in human gastric cancer cells. Lab Invest 2001; 81: 349–360
   PubMed Web of Science ®Google Scholar
• Gallois C., Habib A., Tao J., Moulin S., Maclouf J., Mallat A., et al. Role of NF-kappa B in the antiproliferative effect of endothelin-1 and tumor necrosis factor-alpha in human hepatic stellate cells. Involvement of cyclooxygenase-2. J Biol Chem 1998; 273: 23183–23190
   PubMed Web of Science ®Google Scholar
• Kojima M., Morisaki T., Izuhara K., Uchiyama A., Matsunari Y., Katano M., et al. Lipopolysaccharide increases cyclo-oxygenase-2 expression in a colon carcinoma cell line through nuclear factor-kappa B activation. Oncogene 2000; 19: 1225–1231
   PubMed Web of Science ®Google Scholar
• Liu S., Khemlani L. S., Shapiro R. A., Johnson M. L., Liu K., Geller D. A., et al. Expression of CD14 by hepatocytes: upregulation by cytokines during endotoxemia. Infect Immun 1998; 66: 5089–5098
   PubMed Web of Science ®Google Scholar
• Elder D. J., Halton D. E., Hague A., Paraskeva C. Induction of apoptotic cell death in human colorectal carcinoma cell lines by a cyclooxygenase-2 (COX-2)-selective nonsteroidal anti-inflammatory drug: independence from COX-2 protein expression. Clin Cancer Res 1997; 3: 1679–1683
   PubMed Web of Science ®Google Scholar
• Piazza G. A., Alberts D. S., Hixson L. J., Paranka N. S., Li H., Finn T., et al. Sulindac sulfone inhibits azoxymethane-induced colon carcinogenesis in rats without reducing prostaglandin levels. Cancer Res 1997; 57: 2909–2915
   PubMed Web of Science ®Google Scholar
• Li M., Lotan R., Levin B., Tahara E., Lippman S. M., Xu X. C. Aspirin induction of apoptosis in esophageal cancer: a potential for chemoprevention. Cancer Epidemiol Biomarkers Prev 2000; 9: 545–549
   PubMed Web of Science ®Google Scholar
• Siebenlist U., Franzoso G., Brown K. Structure, regulation and function of NF-kappa B. Annu Rev Cell Biol 1994; 10: 405–455
   PubMedGoogle Scholar
• Wulczyn F. G., Krappmann D., Scheidereit C. The NF-kappa B/Rel and I kappa B gene families: mediators of immune response and inflammation. J Mol Med 1996; 74: 749–769
   PubMed Web of Science ®Google Scholar
• Pierce J. W., Read M. A., Ding H., Luscinskas F. W., Collins T. Salicylates inhibit Ikappa B-alpha phosphorylation, endothelial-leukocyte adhesion molecule expression, and neutrophil transmigration. J Immunol 1996; 156: 3961–3969
   PubMed Web of Science ®Google Scholar
• Yin M. J., Yamamoto Y., Gaynor R. B. The anti-inflammatory agents aspirin and salicylate inhibit the activity of I (kappa)B kinase-beta. Nature 1998; 396: 77–80
   PubMed Web of Science ®Google Scholar
• Sovak M. A., Bellas R. E., Kim D. W., Zanieski G. J., Rogers A. E., Traish A. M., Sonenshein G. E. Aberrant nuclear factor-kappaB/Rel expression and the pathogenesis of breast cancer. J Clin Invest 1997; 100: 2952–2960
   PubMed Web of Science ®Google Scholar
• Liu J. F., Jamieson G. G., Drew P. A., Zhu G. J., Zhang S. W., Zhu T. N., et al. Aspirin induces apoptosis in esophageal cancer cells by inhibiting the pathway of NF-kappaB downstream regulation of cyclooxygenase-2. ANZ J Surg 2005; 75: 1011–1016
   PubMed Web of Science ®Google Scholar